Many inflammatory stress molecules and pathways including Ang II-associated hypertensive stress, diabetes-related metabolic stress, cytokine storm, high CRP, overreactive TGF-β signaling, complement activation, and lung-kidney crosstalk may promote AKI in COVID-19 patients. The gene discussed is AGT; the disease is COVID-19.